Novartis focuses on innovative medicines as well as generics and biosimilars.
We are a leading global medicines company powered by data and digital. We harness the power of science to push boundaries, develop breakthrough treatments and deliver them directly to the millions of people in the UK who need them.
At Novartis we are reimagining medicine in terms of how we fight disease, deliver treatments to patients and operate as a company. Today, we are working on exciting new innovations that, just a few years ago, were the stuff of science fiction.
Our specialist business units, Novartis Oncology and Novartis Pharmaceuticals, form our Innovative Medicines Division.
Novartis Oncology is dedicated to revolutionising the development of innovative medicines for a variety of cancers and rare diseases.
Novartis Pharmaceuticals focuses on the delivery of innovative treatments in the areas of cardiovascular, respiratory, neuroscience, ophthalmology, immunology, hepatology and dermatology.
Generics and Biosimilars
Sandoz is a global leader in generic medicines and biosimilars. It is committed to driving access to high-quality medicines around the world. In the UK, Sandoz has a long history of providing affordable products to the NHS. For more information, please visit: www.sandoz.uk.com.
Learn more about why we do what we do - watch our video below!